Rapidly progressive interstitial lung disease due to anti-MDA5 antibodies without skin involvement: a case report and literature review. [electronic resource]
- Rheumatology international 07 2018
- 1293-1296 p. digital
Publication Type: Case Reports; Journal Article; Review
1437-160X
10.1007/s00296-018-3991-7 doi
Anti-Inflammatory Agents--therapeutic use Autoantibodies Cyclosporine--therapeutic use Dermatomyositis--immunology Female Humans Interferon-Induced Helicase, IFIH1--immunology Lung Diseases, Interstitial--drug therapy Methylprednisolone--therapeutic use Middle Aged